- $2.43bn
- $4.96bn
- $4.14bn
Annual income statement for Calumet, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,148 | 4,686 | 4,181 | 4,189 | 4,137 |
| Cost of Revenue | |||||
| Gross Profit | 143 | 352 | 452 | 231 | 246 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3,234 | 4,596 | 3,920 | 4,182 | 4,076 |
| Operating Profit | -85.6 | 90.5 | 261 | 7.7 | 61.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -259 | -170 | 49.7 | -221 | -126 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -260 | -173 | 48.1 | -222 | -33.8 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -260 | -173 | 48.1 | -222 | -33.8 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -255 | -170 | 47.1 | -222 | -33.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.07 | -0.666 | -0.908 | -2.48 | -0.924 |